Prognostic analysis of surgical-pathologic N1 disease in non-small cell lung cancer: Single-center experience with 276 cases
OBJECTIVE: Patients who receive surgical treatment due to non-small cell lung cancer (NSCLC) and have surgical-pathologic N1 (pN1) disease represent a heterogeneous group. Differences in lymph node (LN) level (hilar or intrapulmonary LNs) may influence patient survival. The aim of this study was to...
Main Authors: | Serkan Yazgan, Ahmet Ucvet, Soner Gursoy, Ozgur Samancilar, Ezgi Cimen Guvenc |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Eurasian Journal of Pulmonology |
Subjects: | |
Online Access: | http://www.eurasianjpulmonol.com/article.asp?issn=2148-5402;year=2018;volume=20;issue=3;spage=144;epage=149;aulast=Yazgan |
Similar Items
-
S1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
by: Meng-Che Hsieh, et al.
Published: (2020-08-01) -
Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma
by: Kunwei Peng, et al.
Published: (2021-03-01) -
Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
by: Jiazhang Xing, et al.
Published: (2021-09-01) -
Breast Cancer Prognostication by Pathologic Node Staging (pN-staging) System Versus Lymph Node Ratio (LNR): A Critical Review of Conflicts With Number of Nodes, Z-0011 Trial , Staging Cut-points, Neo-adjuvant Therapy, and Survival Estimation
by: Amin Safavi, et al.
Published: (2017-12-01) -
Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant Therapy
by: Marco Chiappetta, et al.
Published: (2021-03-01)